Development of plasma derivatives for clinical use.
D000143:Acids; D000925:Anticoagulants; D001771:Blood Banks; D001798:Blood Proteins / Q000302:isolation & purification*; D001803:Blood Transfusion; D002951:Citrates; D005169:Factor VIII / Q000302:isolation & purification; D005947:Glucose; D006062:Gonadotropins / Q000627:therapeutic use; D006801:Humans; D007070:Immunoglobulin A / Q000627:therapeutic use; D007075:Immunoglobulin M / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008670:Metals; D010710:Phosphates; D010949:Plasma; D011485:Protein Binding; D012011:Red Cross; D012109:Research Support as Topic; D012709:Serum Albumin / Q000302:isolation & purification; D013045:Species Specificity; D005719:gamma-Globulins / Q000302:isolation & purification
D000143:Acids; D000925:Anticoagulants; D001798:Blood Proteins; D002951:Citrates; D006062:Gonadotropins; D007070:Immunoglobulin A; D007075:Immunoglobulin M; D007328:Insulin; D008670:Metals; D010710:Phosphates; D012709:Serum Albumin; D005719:gamma-Globulins; D005169:Factor VIII; D005947:Glucose